首页> 外文期刊>CNS oncology. >CNS metastasis secondary to malignant-mixed MuIIerian tumor: case report and review of therapeutics
【24h】

CNS metastasis secondary to malignant-mixed MuIIerian tumor: case report and review of therapeutics

机译:CNS转移继发于恶性混合毛利安肿瘤:病例报告和治疗方法审查

获取原文
获取原文并翻译 | 示例
           

摘要

This paper reviews CNS involvement secondary to malignant-mixed Muilerian tumor or uterine carcinosar-coma, a rare aggressive biphasic Muilerian tumor. We report a cerebellar metastasis with epithelial and mesenchymal components, demonstrating heterologous rhabdomyogenic and chondroblastic differentiation. The patient had undergone total abdominal hysterectomy and bilateral salpingo-oophorectomy for palliation of symptomatic chemotherapy-resistant node-positive disease. CNS involvement is rare, and prognostically poor, and suggestively poorer in predominantly sarcomatous metastases. Multimodal therapy is indicated; in solitary metastases, surgical resection or stereotactic radiosurgery is included, followed by whole brain radiotherapy. In unresectable brain metastases, stereotactic radiosurgery and whole brain radiotherapy warrant consideration in up to 2-3 metastases. In multiple metastases, palliative steroid therapy or cranial irradiation may be considered. Combination or platinum-based chemotherapy (i.e., ifosfamide-paclitaxel or carboplatin-paclitaxel) is indicated in all stages, with a role in both disease cure and control-directed management. Targeted therapeutics have thus far not demonstrated significant clinical efficacy.
机译:本文评论中枢参与中的继发于恶性混合的Muilerian肿瘤或子宫癌 - 昏迷,一种罕见的腐蚀性双相瘤。我们报告了具有上皮和间充质成分的小脑转移,证明了异源r蛛囊性和软骨髓细胞分化。患者经历了总腹腔切除术和双侧Salpingo-Oophorectomy,用于症状化疗抗性节点阳性疾病的粘连。 CNS参与是罕见的,预后贫困,并且略微较差,主要是SARCATOUS转移。表明多式化疗法;在孤零性转移中,包括外科切除或立体定向放射牢,然后是全脑放射治疗。在不可切除的脑转移中,立体定向放射外科和全脑放射疗法的认证在最多2-3个转移中的考虑。在多种转移中,可能考虑姑息类固醇治疗或颅辐射。组合或铂化疗(即,IFOSFamide-PACLITAXEL或CARBOPOLATIN-PACLITAXEL)在所有阶段中表明,疾病治愈和对照的管理中作用。目前靶向治疗措施远未表现出显着的临床疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号